NUVA

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Nuvasive Inc

NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With over $1 billion in revenues, NuVasive has an approximate 2,400-person workforce in more than 40 countries serving surgeons, hospitals and patients.
CEO
J. Christopher Barry
Employees
2700
Headquarters

7475 Lusk Blvd
San Diego, California 92121-5707
Phone: 18589091800
www.nuvasive.com

News

Globus Medical, NuVasive complete merger
Sep 01, 2023 19:55pm

… completion of their previously announced merger . The news sent GMED shares … discuss the closing of the merger and its potential benefits … David Paul said. “I’ m incredibly proud of the strong … surgeon customers and their patients as a combined company.” In …


Source:EIN News Merge and Acquisitions
Jackson financial, Goosehead Insurance to join S&P SmallCap 600
Aug 29, 2023 00:37am

Planned changes to the S&P SmallCap 600 include Jackson Financial (JXN) replacing NexTier Oilfield Solutions (NEX) and Goosehead Insurance (GSHD) replacing NuVasive (NUVA), S&P Dow…


Source:Seeking Alpha
NuVasive gains amid Nasdaq delisting notice for Globus Medical deal
Aug 28, 2023 17:41pm

NuVasive (NUVA) rose 3% amid a Nasdaq delisting notice for its planned sale to Globus Medical (GMED)


Source:Seeking Alpha
NuVasive reports increased net sales in second-quarter 2023 financial results
Aug 06, 2023 13:19pm

#NuVasive #reports #increased #net #sales #secondquarter #financial #results NuVasive Inc. has reported increased net sales for the second quarter of 2023, citing the adoption of new products and increased procedural volumes as driving factors. The company announced net sales of $317.8 million, a 2.4% increase compared to the previous year. In addition, NuVasive reported a …


Source:Dataemia